Insider Transactions in Q1 2024 at Zentalis Pharmaceuticals, Inc. (ZNTL)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 12
2024
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
1,173
-0.18%
|
$12,903
$11.44 P/Share
|
|
Feb 12
2024
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,573
-0.57%
|
$28,303
$11.44 P/Share
|
|
Feb 02
2024
|
Andrea Paul Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,310
-2.16%
|
$36,410
$11.54 P/Share
|
|
Feb 02
2024
|
Mark Lackner Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,585
-0.8%
|
$17,435
$11.54 P/Share
|
|
Feb 02
2024
|
Epperly Melissa B, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,669
-1.87%
|
$95,359
$11.54 P/Share
|
|
Feb 02
2024
|
Cam Gallagher President, Interim CFO |
SELL
Open market or private sale
|
Direct |
11,552
-1.76%
|
$127,072
$11.54 P/Share
|
|
Feb 01
2024
|
Andrea Paul Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,500
+42.33%
|
-
|
|
Feb 01
2024
|
Mark Lackner Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
141,000
+41.68%
|
-
|
|
Feb 01
2024
|
Diana Hausman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
337,500
+47.22%
|
-
|
|
Feb 01
2024
|
Kimberly Blackwell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,655
-4.09%
|
$227,205
$11.69 P/Share
|
|
Feb 01
2024
|
Kimberly Blackwell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+33.12%
|
-
|
|
Feb 01
2024
|
Epperly Melissa B, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+13.95%
|
-
|
|
Feb 01
2024
|
Cam Gallagher President, Interim CFO |
BUY
Grant, award, or other acquisition
|
Direct |
192,500
+22.69%
|
-
|
|
Jan 02
2024
|
Mark Lackner Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+41.53%
|
-
|